We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Cryo-Save | LSE:CRYO | London | Ordinary Share | NL0009272137 | ORD EUR0.10 (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 420.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
TIDMCRYO
RNS Number : 2438J
Cryo-Save Group NV
26 March 2010
26 March 2010
Cryo-Save Group N.V.
Director/PDMR Shareholding
Cryo-Save Group N.V., Europe's leading stem cell bank, has been informed that on
25 March 2010 Marc Waeterschoot, Chief Executive Officer, transferred 100,000
ordinary shares of Euro 0.10 ('Ordinary Shares') from Life-Sciences N.V., a
company controlled by him, into his personal Cryo-Save holdings.
As a result of the transaction, Marc Waeterschoot's beneficial interest in
Cryo-Save remains unchanged at 1,792,704 Ordinary Shares, representing
approximately 19.41% of the Company's issued share capital.
+------------------------------+----------------------------+
| Enquiries: | |
+------------------------------+----------------------------+
| | |
+------------------------------+----------------------------+
| Cryo-Save Group | + |
| | 31 (0)575 548998 |
+------------------------------+----------------------------+
| Marc Waeterschoot, Chief | |
| Executive | |
+------------------------------+----------------------------+
| Arnoud van Tulder, Chief | |
| Financial Officer | |
+------------------------------+----------------------------+
| | |
+------------------------------+----------------------------+
| Daniel Stewart & Company plc | + |
| | 44 (0) 20 7776 6550 |
+------------------------------+----------------------------+
| Simon Leathers / Emma Earl | |
+------------------------------+----------------------------+
| | |
+------------------------------+----------------------------+
| College Hill (UK) | + |
| | 44 (0) 20 7457 2020 |
+------------------------------+----------------------------+
| Adrian Duffield/Rozi Morris | |
+------------------------------+----------------------------+
SPJ Financiële Communicatie Amstelveen (Netherlands) + 31 (0)206478181
Kees Jongsma/Leon Melens
About Cryo-Save
With more than 120,000 samples saved, Cryo-Save is the leading stem cell bank in
Europe and one of the fastest growing in the world. Driven by its international
business strategy, Cryo-Save is now represented in 38 countries on three
continents and has state-of-the-art processing facilities in Belgium, Germany,
Dubai, India and France (under construction).
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLIFETVTIRFII
1 Year Cryo-Save Chart |
1 Month Cryo-Save Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
